JOIN THE BATTLE. Beat Rare Cancers.
OUR TEAM IS RIDING TO BEAT RARE CANCERS!
Welcome to our team page! We are riding and raising money for Cycle for Survival, the movement to beat rare cancers.
As team captain, I wanted to personally thank you for visiting our team page and considering joining the fight to beat rare cancer. This is my 4th year participating in Cycle For Survival and raising money for Memorial Sloan Kettering.
During my the second semester of my senior year at Wake Forest University, one of my closest friends was diagnosed with Ewings Sarcoma cancer. What first started out as a fun night out on the town, soon turned into stomach pains, possible appendicitis, and a whole day in the ER cracking jokes to try to stay calm. Erin had just been accepted into law school when she received her diagnosis, and it was devastating. After two round of chemotherapy and treatment at Memorial Sloan Kettering, Erin lost her battle with cancer at age 22.
Erin was a fighter, pushing through cancer and treatment to still graduate on time with a stellar GPA and crushing all her final exams. She remained positive throughout her whole treatment, always still making time for others and being the best friend imaginable. I am still in awe of her positivity and ability to fight and stay strong, despite all that was thrown at her.
I first joined Cycle For Survival as a way to give back to the doctors and team that treated Erin at Memorial Sloan Kettering. I soon learned that the cause it so much more than "giving money", as 100% of donations directly fund innovative studies and clinical trials led by the cancer center, treatments and trials that helped provide care for Erin. Memorial Sloan Kettering (MSK) is truly revolutionizing how cancer is diagnosed and treated, benefitting patients everywhere.
Join our team or donate today.
Your gift will help give people with rare cancers a better future through new and improved treatments. Since 2007, Cycle for Survival supporters have provided resources to hundreds of doctors and scientists to pursue bold ideas that have led to the FDA approval of new drugs, lifesaving clinical trials, and four state-of-the-art DNA sequencers that are aiding in key cancer discoveries.
Thank you for supporting us!
If you think this page contains objectionable content, please inform the system administrator.